Today’s top gainers include the company AstraZeneca PLC (NYSE:AZN) which is in the industry Drug Manufacturers – Major, gaining -0.13% today. In the last week its performance is 1.36%, and 1.33% for the past quarter. Currently, AstraZeneca PLC, AZN has a target price of 34.41, so today’s gain of -0.13% is a significant step towards its target price. The GAP today is therefore -0.43%.
AstraZeneca PLC (NYSE:AZN), has a market cap of 77280.96, and is based in United Kingdom. Insider ownership is at 0.50%, and institutional ownership is 10.80%.
At the current price of 30.53, it has a dividend yield of 6.22%, and its target price is 34.41. This is with a profit margin of 11.80%, and total debt/equity of 1.11. AstraZeneca PLC (NYSE:AZN) has a P/E of 26.47, as well as a forward P/E of 13.59.
With a current EPS of 1.16, and a forecasted EPS growth for next year at -4.50%,AstraZeneca PLC (NYSE:AZN) has had a EPS growth for the past five years at -16.70%. For the next five years EPS growth is projected to be -1.00%.
Performance for the year is -5.44%. Since its IPO date on 5/17/1993, the total performance to date is -7.04%.
Volume today for AstraZeneca PLC (NYSE:AZN), is 6399083, while its average volume is 4771.21. Whilst the total gain today was -0.13%, it did have a day high of -0.65%.
Volatility for this week has been at 1.03%, and 1.60% for the month. The 52-week low for AstraZeneca PLC, AZN has been 13.20%, while the 52-week-high has reached -9.64%.
Looking at its return of investments, which is 11.50%, and its return on assets is 5.00%. AstraZeneca PLC (NYSE:AZN) has an operating margin of 17.00%. With a sales growth of 1.00% quarter over quarter. Bearing in mind that AstraZeneca PLC, AZN is in the sector Healthcare, its long-term debt/equity is 0.96, and has a current ratio of 0.8 and 0.7 for quick ratio.
So what is the value of AstraZeneca PLC? Well its PEG is *TBA, and the P/S is 3.12, along with a P/B of 5.24. Meanwhile it has a p/cash of 18.85.